Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Dargis

Anthony Dargis, Hunterdon County, NJ US

Patent application numberDescriptionPublished
20090094691Intranet client protection service - A system and method for protecting intranet client devices in a virtual private network are disclosed. The method includes defining one or more groups of client devices to protect from traffic emanating from an external network (e.g., Internet, a Wide Area Network (WAN), a remote subnet of an intranet, and the like), while allowing the client devices to initiate TCP sessions with servers in the outside network.04-09-2009

Anthony Dargis, Flemington, NJ US

Patent application numberDescriptionPublished
20100037309METHOD AND APPARATUS FOR PROVIDING SECURITY IN AN INTRANET NETWORK - A method and an apparatus for providing security in an intranet network are disclosed. For example, the method receives a packet at a customer edge router, and applies an inbound access control list by the customer edge router to the packet if the packet is destined to a server in a protected server group, wherein said protected server group identifies one or more servers within the intranet network to be protected. The method applies an outbound access control list by the customer edge router to the packet if the packet is from a server in the protected server group.02-11-2010

Anthony B. Dargis, Flemington, NJ US

Patent application numberDescriptionPublished
20110107410METHODS, SYSTEMS, AND COMPUTER PROGRAM PRODUCTS FOR CONTROLLING SERVER ACCESS USING AN AUTHENTICATION SERVER - An access request message is received at an authentication server computer, the access request message identifying an address of an access requesting client device. The authentication server authenticates the access request message and transmits an access authorization message from the authentication server computer to a blocking device that controls access to the protected server computer, the access authorization message identifying the address of the access requesting client device. Access to the protected server computer via the blocking device is controlled responsive to the access authorization message.05-05-2011
20110154468METHODS, SYSTEMS, AND COMPUTER PROGRAM PRODUCTS FOR ACCESS CONTROL SERVICES USING A TRANSPARENT FIREWALL IN CONJUNCTION WITH AN AUTHENTICATION SERVER - Access control methods include receiving an access authorization message from an authentication server computer at a blocking device that connects a first network to a second network, modifying access criteria of a transparent firewall at the blocking device responsive to the received access authorization message and operating the transparent firewall according to the modified access criteria to control transfer of messages between the first and second networks. The invention may also be implemented as apparatus and computer readable media.06-23-2011
20110154469METHODS, SYSTEMS, AND COMPUTER PROGRAM PRODUCTS FOR ACCESS CONTROL SERVICES USING SOURCE PORT FILTERING - An authentication request message is received at an authentication server computer, the authentication request message identifying a requesting client device. The authentication request message is authenticated at the authentication server computer and, responsive to authentication of the authentication request message, a source port for a redirected communication between the requesting client device associated and the protected server is determined. An access authorization message identifying the determined source port is transmitted from the authentication server computer to a blocking device that controls access to the protected server. A redirect message may be transmitted from the authentication server to a browser resident at the client device responsive to authentication of the authentication request message. Embodiments include methods, apparatus and computer readable media.06-23-2011

Brooth R. Dargis, New York, NY US

Patent application numberDescriptionPublished
20120100602BIOREACTOR SYSTEM FOR MECHANICAL STIMULATION OF BIOLOGICAL SAMPLES - The subject application provides an apparatus for applying mechanical loading to a biological sample, said apparatus comprising: a bioreactor device configured to house the biological sample, and a load application unit for applying mechanical loading to the biological sample housed in the bioreactor device, said load application unit including: a) a first sliding arm for applying mechanical displacement to the biological sample in the bioreactor device in a first predetermined direction; and b) a guide rail coupled to the first sliding arm to limit movement of the first sliding arm such that the first sliding arm moves only in the first predetermined direction when displaced.04-26-2012

Michéle Dargis, Quebec CA

Patent application numberDescriptionPublished
20100239610INFLUENZA VIRUS-LIKE PARTICLES (VLPS) COMPRISING HEMAGGLUTININ PRODUCED WITHIN A PLANT - A method for synthesizing influenza virus-like particles (VLPs) within a plant or a portion of a plant is provided. The method involves expression of influenza HA in plants and the purification by size exclusion chromatography. The invention is also directed towards a VLP comprising influenza HA protein and plants lipids. The invention is also directed to a nucleic acid encoding influenza HA as well as vectors. The VLPs may be used to formulate influenza vaccines, or may be used to enrich existing vaccines.09-23-2010
20100310604RECOMBINANT INFLUENZA VIRUS-LIKE PARTICLES (VLPS) PRODUCED IN TRANSGENIC PLANTS EXPRESSING HEMAGGLUTININ - A method for synthesizing influenza virus-like particles (VLPs) within a plant or a portion of a plant is provided. The method involves expression of influenza HA in plants and the purification by size exclusion chromatography. The invention is also directed towards a VLP comprising influenza HA protein and plants lipids. The invention is also directed to a nucleic acid encoding influenza HA as well as vectors. The VLPs may be used to formulate influenza vaccines, or may be used to enrich existing vaccines.12-09-2010
20110104753Soluble Recombinant Influenza Antigens - The present invention provides a recombinant soluble trimeric hemagglutinin (rHA) protein comprising a hemagglutinin ectodomain and an oligomerization domain. The rHA is produced as a soluble homotrimer, and may further comprises a signal peptide and/or an endoplasmic reticulum (ER) retention signal. The invention is also directed to nucleic acids encoding the rHA of the invention, as well as vectors and chimeric constructs comprising the nucleic acid. Methods of producing the rHA are also provided. The rHA described herein may be used to formulate influenza vaccines, or may be used to enrich existing vaccines.05-05-2011

Michéle Dargis, Quebec CA

Patent application numberDescriptionPublished
20100239610INFLUENZA VIRUS-LIKE PARTICLES (VLPS) COMPRISING HEMAGGLUTININ PRODUCED WITHIN A PLANT - A method for synthesizing influenza virus-like particles (VLPs) within a plant or a portion of a plant is provided. The method involves expression of influenza HA in plants and the purification by size exclusion chromatography. The invention is also directed towards a VLP comprising influenza HA protein and plants lipids. The invention is also directed to a nucleic acid encoding influenza HA as well as vectors. The VLPs may be used to formulate influenza vaccines, or may be used to enrich existing vaccines.09-23-2010
20100310604RECOMBINANT INFLUENZA VIRUS-LIKE PARTICLES (VLPS) PRODUCED IN TRANSGENIC PLANTS EXPRESSING HEMAGGLUTININ - A method for synthesizing influenza virus-like particles (VLPs) within a plant or a portion of a plant is provided. The method involves expression of influenza HA in plants and the purification by size exclusion chromatography. The invention is also directed towards a VLP comprising influenza HA protein and plants lipids. The invention is also directed to a nucleic acid encoding influenza HA as well as vectors. The VLPs may be used to formulate influenza vaccines, or may be used to enrich existing vaccines.12-09-2010
20110104753Soluble Recombinant Influenza Antigens - The present invention provides a recombinant soluble trimeric hemagglutinin (rHA) protein comprising a hemagglutinin ectodomain and an oligomerization domain. The rHA is produced as a soluble homotrimer, and may further comprises a signal peptide and/or an endoplasmic reticulum (ER) retention signal. The invention is also directed to nucleic acids encoding the rHA of the invention, as well as vectors and chimeric constructs comprising the nucleic acid. Methods of producing the rHA are also provided. The rHA described herein may be used to formulate influenza vaccines, or may be used to enrich existing vaccines.05-05-2011
20110293650INFLUENZA VIRUS-LIKE PARTICLES (VLPS) COMPRISING HEMAGGLUTININ - A method for synthesizing influenza virus-like particles (VLPs) within a plant or a portion of a plant is provided. The method involves expression of influenza HA of type A/California/04/09 in plants and the purification by size exclusion chromatography. The invention is also directed towards a VLP comprising influenza HA protein of type A/California/04/09 and plants lipids. The invention is also directed to a nucleic acid encoding influenza HA of type A/California/04/09 as well as vectors. The VLPs may be used to formulate influenza vaccines, or may be used to enrich existing vaccines.12-01-2011

Rytis Dargis, Fremont, CA US

Patent application numberDescriptionPublished
20120104443IIIOxNy ON SINGLE CRYSTAL SOI SUBSTRATE AND III n GROWTH PLATFORM - A silicon-on-insulator (SOI) substrate structure and method of fabrication including a single crystal silicon substrate, a layer of single crystal rare earth oxide formed on the substrate, a layer of engineered single crystal silicon formed on the layer of single crystal rare earth oxide, and a single crystal insulator layer of IIIO05-03-2012